2019
DOI: 10.1038/s41430-019-0468-z
|View full text |Cite|
|
Sign up to set email alerts
|

Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
3

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 9 publications
0
17
3
Order By: Relevance
“…In contrast to our data in liver cirrhosis, in patients with peritoneal dialysis the definition from 2010 identified less patients as sarcopenic compared to the 2019 definition (4% versus 10%) [23]. In this study, however, muscle mass was assessed using dual energy x-ray absorptiometry (DEXA), which might also be a reason for the discrepant results compared to liver cirrhosis [23]. Large differences in the prevalence of sarcopenia between CT scan (70.3%) and DEXA (38.7%) were also found in patients with chronic liver disease [24].…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…In contrast to our data in liver cirrhosis, in patients with peritoneal dialysis the definition from 2010 identified less patients as sarcopenic compared to the 2019 definition (4% versus 10%) [23]. In this study, however, muscle mass was assessed using dual energy x-ray absorptiometry (DEXA), which might also be a reason for the discrepant results compared to liver cirrhosis [23]. Large differences in the prevalence of sarcopenia between CT scan (70.3%) and DEXA (38.7%) were also found in patients with chronic liver disease [24].…”
Section: Discussioncontrasting
confidence: 99%
“…A couple of studies already compared the 2010 and the 2019 criteria in elderly and in in different disease cohorts. In contrast to our data in liver cirrhosis, in patients with peritoneal dialysis the definition from 2010 identified less patients as sarcopenic compared to the 2019 definition (4% versus 10%) [23]. In this study, however, muscle mass was assessed using dual energy x-ray absorptiometry (DEXA), which might also be a reason for the discrepant results compared to liver cirrhosis [23].…”
Section: Discussioncontrasting
confidence: 86%
“…The prevalence of sarcopenia in chronic kidney disease (CKD) patients varies widely, ranging from 4.0% to 13.7% depending on the CKD stage, kidney replacement therapy (KRT), and the consensus version [1][2][3]. This number is even higher in CKD patients aged 60 years and above [3].…”
Section: Introductionmentioning
confidence: 99%
“…This was a secondary analysis of data from a study previously published (14), which enrolled patients aged 18 years or above, with CKD on PD (for at least 3 months) at the Dialysis Unit from the Clinics Hospital of Botucatu Medical School (Botucatu, Brazil). The protocol was approved by the Ethics and Research Committee (CAAE 61634816.4.0000.5411), and the participants gave written informed consent.…”
Section: Methodsmentioning
confidence: 99%